Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring

Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health Monitoring GlobeNewswire December 18, 2025 Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing technologies Alliance positions INBS to […]

Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026

Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026 GlobeNewswire December 18, 2025 DOYLESTOWN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that target weaknesses in cancer cells while minimizing damage to healthy

VisionWave Holdings Acquires Solar Drone Ltd., Advancing Autonomous Systems for Defense and Critical Infrastructure

VisionWave Holdings Acquires Solar Drone Ltd., Advancing Autonomous Systems for Defense and Critical Infrastructure GlobeNewswire December 18, 2025 WEST HOLLYWOOD, Calif. and TEL AVIV, Israel, Dec. 18, 2025 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), a multi-domain technology company building next-generation autonomous robotics, RF imaging, and AI-driven sensing, today announced

GSI Technology to Participate Virtually in the 28th Annual Needham Growth Conference on January 15, 2026

GSI Technology to Participate Virtually in the 28th Annual Needham Growth Conference on January 15, 2026 GlobeNewswire December 18, 2025 SUNNYVALE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute processing, providing true compute-in-memory

Data Storage Corporation Provides Letter to Shareholders Highlighting 2026 Corporate Strategy

Data Storage Corporation Provides Letter to Shareholders Highlighting 2026 Corporate Strategy GlobeNewswire December 18, 2025 MELVILLE, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“Data Storage” or the “Company”), today provided a letter to shareholders from its CEO, Chuck Piluso. Dear Valued Shareholders, As we look ahead to 2026, I would

Byrna Technologies to Ring the Nasdaq Opening Bell on December 22, 2025

Byrna Technologies to Ring the Nasdaq Opening Bell on December 22, 2025 GlobeNewswire December 18, 2025 ANDOVER, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today announced that it

Sodium Benzoate Market worth $372.3 million by 2030 at 4.1%, says MarketsandMarkets(TM)

Sodium Benzoate Market worth $372.3 million by 2030 at 4.1%, says MarketsandMarkets(TM) GlobeNewswire December 18, 2025 Delray Beach, FL, Dec. 18, 2025 (GLOBE NEWSWIRE) — In terms of value, the Sodium Benzoate Market is projected to grow from USD 304.9 million in 2025 to USD 372.3 million by 2030 at a CAGR of 4.1%., as

Biodexa Announces Pricing of $10 Million Public Offering

Biodexa Announces Pricing of $10 Million Public Offering GlobeNewswire December 18, 2025 December 18, 2025 Biodexa Announces Pricing of $10 Million Public Offering Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “Company”), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium GlobeNewswire December 18, 2025 THE WOODLANDS, TX, Dec. 18, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced

Picard Medical Marks Public Company Milestone by Ringing the NYSE Opening Bell

Picard Medical Marks Public Company Milestone by Ringing the NYSE Opening Bell Picard Medical, Inc. / SynCardia Systems LLC commemorate the Company's transition to the public markets and continued advancement of their Total Artificial Heart technology GlobeNewswire December 18, 2025 TUCSON, Ariz., Dec. 18, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE: PMI) (“Picard” or

Scroll to Top